Table 2. Doses of IPTp-SP taken during pregnancy among women with 2 or more qualifying ANC visits.
| Number of doses of SP-IPT1 | n (%) |
| Full course | 86 (31.3) |
| ≥2 doses in 2nd AND 3rd trimesters | 64 |
| ≥2 doses in 2nd or 3rd trimesters | 22 |
| Partial course | 79 (28.7) |
| <2 doses in 2nd or 3rd trimesters, no incorrect doses | 73 |
| <2 doses in 2nd or 3rd trimesters, plus 1st trimester use | 6 |
| None | 110 (40.0) |
| 0 doses | 109 |
| 1st trimester use only | 1 |
1
(n = 275): Excludes women without qualifying ANC visits in the 2nd and 3rd trimester (n = 46), women using SP for the treatment of malaria (n = 179).